The role of different amygdala nuclei (neuroanatomical subdivisions) in processing Pavlovian conditioned fear has been studied extensively, but the function of the heterogeneous neuronal subtypes within these nuclei remains poorly understood. Here we use molecular genetic approaches to map the functional connectivity of a subpopulation of GABA-containing neurons, located in the lateral subdivision of the central amygdala (CEl), which express protein kinase C-d (PKC-d). Channelrhodopsin-2-assisted circuit mapping in amygdala slices and cell-specific viral tracing indicate that PKC-d 1 neurons inhibit output neurons in the medial central amygdala (CEm), and also make reciprocal inhibitory synapses with PKC-d 2 neurons in CEl. Electrical silencing of PKC-d 1 neurons in vivo suggests that they correspond to physiologically identified units that are inhibited by the conditioned stimulus, called CEl off units. This correspondence, together with behavioural data, defines an inhibitory microcircuit in CEl that gates CEm output to control the level of conditioned freezing.
The amygdala is a medial temporal lobe region that is central to the acquisition and expression of Pavlovian conditioned fear [1] [2] [3] . The amygdala contains multiple anatomically defined nuclei 4 . Associative learning occurs largely in the lateral nucleus, whereas the central nucleus is thought to control the expression of fear 5, 6 . However, the central nucleus contains at least three subnuclei (CEm, CEl and capsular central amygdala) 3, 4 and multiple neuronal subtypes 7-10 whose role is poorly understood. A full understanding of amygdala function requires its dissection at the cellular level.
Here we have used genetic methods to investigate the functional connectivity and behavioural relevance of a GABAergic subpopulation within CEl [11] [12] [13] , marked by the expression of PKC-d. These neurons inhibit output neurons in CEm and also make reciprocal inhibitory connections with PKC-d 2 neurons within CEl. Genetic silencing 14, 15 in conjunction with in vivo electrophysiology indicates that these neurons probably correspond to 'CEl off ' units identified in the accompanying paper 16 that are inhibited by the conditioned stimulus (CS). Taken together, these data define the functional connectivity and behavioural relevance of an inhibitory microcircuit within CEl 9,17 that gates output from CEm 12 .
Properties of PKC-d 1 neurons in CEl
We sought stable markers for subpopulations in the central nucleus 18, 19 , which could be used to genetically manipulate their activity in vivo [20] [21] [22] . PKC-d marks about 50% of CEl GABAergic neurons ( Fig. 1a-d and Supplementary Table 1 ). These neurons are distinct from those expressing corticotropin-releasing hormone 9 (Fig. 1e -g) or dynorphin 10 ( Supplementary Fig. 1a-c) , whereas about 40% express enkephalin 9 (Fig. 1h-j and Supplementary Table 1 ) and about 65% express the oxytocin receptor ( Supplementary Fig. 1d-f and Supplementary  Table 1 ), which is implicated in inhibitory gating of CEm 12 .
We examined the electrophysiological properties of PKC-d 1 neurons in acute amygdala slices. Because of their low spontaneous activity, spiking was evoked by the injection of depolarizing current. This analysis confirmed three types of neuron: late-firing, regular spiking and low-threshold bursting neurons [23] [24] [25] (Fig. 1k, l and Supplementary  Table 2 ). Fills with neurobiotin and staining with antibodies, as well as recording from fluorescently labelled PKC-d 1 neurons in transgenic mice (see below), indicated that most PKC-d 1 neurons are late-firing ( Fig. 1m, o and Supplementary Table 3 ), whereas the PKC-d 2 population contains both regular spiking and late-firing units (Fig. 1n, o and Supplementary Table 3 ). Thus, PKC-d 1 neurons have relatively homogeneous electrophysiological properties ( Supplementary Table 4 ; P , 0.0001, Fisher's exact test).
Functional connectivity of PKC-d 1 neurons
To gain genetic access to PKC-d 1 neurons, transgenic mice were generated 26 harbouring a bacterial artificial chromosome (BAC) expressing Cre recombinase and the a subunit of a cyan fluorescent protein (CFP)-tagged version of the Caenorhabditis elegans glutamate-sensitive chloride channel GluCl (ref. 27) ( Fig. 2a ), separated by an internal ribosome entry site (ires) 28 . Double labelling for GluCla-CFP and PKC-d in these PKC-d:GluCla-ires-Cre mice, as well as crossing to Cre-dependent lacZ-expressing reporter mice, revealed neuronspecific expression of the transgene ( Fig. 2j -m) that correctly recapitulated the pattern of endogenous PKC-d expression ( Fig. 2b- 
CEl is known to contain GABAergic neurons that project to CEm 7, 12, 29, 30 . We traced the anterograde projections of PKC-d 1 neurons to CEm by injecting the CEl of the transgenic mice with a Cre-dependent adeno-associated virus (AAV) encoding humanized Renilla green fluorescent protein 31 (hrGFP) ( Fig. 3a-j ). Recombination of injected AAVs was restricted to PKC-d 1 neurons ( Supplementary Fig. 2f -j). hrGFP 1 fibres derived from CEl projected to CEm (Fig. 3h , inset, and Fig. 3i , j), a result confirmed by retrograde tracing from CEm with the use of the B subunit of cholera toxin (CTB) (Fig. 3k, l) . In all, 60.9 6 5.7% (mean 6 s.e.m., n 5 6) of CTB 1 neurons in CEl were PKC-d 1 (Fig. 3m -o, white arrowhead in inset); the remainder were PKC-d 2 .
Freezing is controlled by projections from CEm to the peri-aqueductal grey (PAG) [32] [33] [34] , but CEm contains multiple neuronal subpopulations with different connectivities 34 . To determine whether PKC-d 1 neurons make inhibitory synapses onto PAG-projecting CEm output neurons, we combined whole-cell patch clamp recording of retrogradely labelled CEm output neurons, with Cre-dependent optogenetic activation 35 of PKC-d 1 neurons (Fig. 3p , q), in acute amygdala slices. Selective expression of channelrhodopsin-2 (ChR2) 36 in PKC-d 1 neurons was achieved by injecting a Cre-dependent AAV encoding yellow fluorescent protein (YFP)-tagged ChR2 (ref. 37) into the CEl of PKCd:GluCla-ires-Cre transgenic mice ( Supplementary Fig. 9a ). Whole-cell patch-clamp recordings from ChR2-expressing PKC-d 1 neurons (identified using native fluorescence for YFP (ChR2) and CFP (GluCla; Supplementary Fig. 9b )) confirmed that spiking could be induced with about 90% efficiency with 473-nm light flashes at 15 Hz ( Supplementary  Fig. 9g ). Retrograde labelling of CEm projection neurons in the same animals was achieved by injection of Alexa-555-conjugated CTB into the PAG (Fig. 3p ), permitting their prospective identification by native fluorescence (Fig. 3q, arrowhead) .
In slices prepared from doubly injected animals, optogenetic activation of CEl PKC-d 1 neurons elicited robust, picrotoxin-sensitive inhibitory postsynaptic currents (IPSCs) in CEm output neurons (success rate 100%) ( Fig. 3r , s; IPSC amplitude 18.3 6 2.3 pA, n 5 6 cells) with an average latency of 3.7 6 0.2 ms (range 2-5 ms, n 5 30) and a mean temporal jitter of 0.83 6 0.16 ms (n 5 6), consistent with monosynaptic transmission 38 . It also suppressed current-injection-evoked action potentials in CEm output neurons ( Fig. 3t , v) in a picrotoxinsensitive manner (Fig. 3u, w) . Thus, CEl PKC-d 1 neurons make inhibitory connections onto PAG-projecting CEm output neurons.
Activation of ChR2-expressing PKC-d 1 neurons by light also evoked monosynaptic IPSCs and suppressed current-injectionevoked action potential firing in CEl PKC-d 2 neurons (identified by the absence of CFP fluorescence), in a picrotoxin-sensitive manner ( Fig. 4a -g). PKC-d 1 neurons therefore also make local inhibitory connections within CEl onto PKC-d 2 neurons.
To determine whether, conversely, PKC-d 1 neurons receive inhibitory input from PKC-d 2 neurons, we employed a cell-specific modification of a virally based monosynaptic retrograde tracing method 39 . PKC-d::GluCla-ires-Cre transgenic mice were first injected with a Cre-dependent AAV encoding both the avian sarcoma/leukosis virus subtype A receptor TVA, and a complementing RV-G protein deleted from the rabies virus strain RV DG (Fig. 4h , left) 40 . Three weeks later, animals were injected in the same site with Env(A)-pseudotyped RV DG virus expressing the red fluorescent protein mCherry ( Fig. 4h , right; see Methods). Because Env(A) directs infection exclusively to TVA-expressing cells 39 , this manipulation yields expression of mCherry in CEl PKC-d 1 neurons in transgenic mice ( Fig. 4m-p ; inset, open arrowheads) but not in wild-type mice ( Fig. 4i , j). Expression of rabies B19 glycoprotein by AAV-infected PKC-d 1 neurons permits the trans-synaptic spread of the RV DG virus to input neurons, but no further spread occurs 39 . Monosynaptic retrograde labelling of PKC-d 2 neurons occurred extensively in CEl ( Fig. 4m , n, p; inset, filled arrowheads), and most labelled neurons were GABAergic 
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activated by the tone ('CEl on ' cells), and units inhibited by it ('CEl off ' cells) ( Fig. 5i -l). We wished to determine whether PKC-d 1 neurons correspond to either of these classes of unit. Because the in vivo recordings employed extracellular electrodes 16 , the cells could not be filled for antibody staining. We therefore examined the effect of reversibly silencing PKC-d 1 neurons on the activity of CEl on and CEl off units, using a mammalian codon-optimized form 41 of the ivermectin-sensitive chloride channel GluCl from C. elegans 14, 15 , mutated to eliminate glutamate sensitivity 27 . Functional expression of this ionotropic receptor requires two subunits, namely GluCla and GluClb. To restrict the expression of GluClab to CEl PKC-d 1 neurons, we employed an intersectional strategy in which GluCla-CFP was expressed transgenically in all PKC-d 1 neurons ( Fig. 2b) , whereas GluClb-YFP 25 was expressed in CEl from an AAV vector by stereotaxic injection ( Fig. 5a and Supplementary Fig. 2a-e ).
We first confirmed silencing of PKC-d 1 neurons by using ivermectin/ GluCl in acute amygdala slices from the mice with intersectional GluClab expression. Neurons expressing GluCla and/or GluClb could be prospectively identified by native CFP and YFP fluorescence, respectively ( Fig. 5c-e ). Bath application of ivermectin decreased the input resistance of cells expressing GluClab, but not that of cells expressing either GluCla or GluClb, from 337 6 41 to 277 6 36 MV (n 5 4, P , 0.04, paired t-test). Ivermectin also significantly suppressed current-injection-evoked spiking in neurons expressing both subunits ( Fig. 5c-h) , as well as subthreshold excitatory postsynaptic potentials evoked by stimulation of the lateral nucleus with a bipolar electrode ( Supplementary Fig. 3 ; this bipolar stimulation did not evoke spiking of PKC-d 1 neurons in our slice preparation).
We next examined the effect of silencing PKC-d 1 neurons on CEl on and CEl off unit activity 16 , in PKC-d::GluCla-ires-Cre transgenic mice previously injected in CEl with the AAV::GluClb virus. CEl on and CEl off units were first identified by CS presentation in conditioned animals, before administration of ivermectin. The spontaneous spiking activity of these units was subsequently measured before, and 3-5 days after, administration of ivermectin. The tonic activity of CEl off units was strongly suppressed after treatment with ivermectin, whereas that of CEl on units was unaffected (Fig. 5m, n ). This effect of ivermectin was reversed within 48 h after treatment (Fig. 5m) , and was not observed in ivermectin-treated uninjected transgenic animals or in virally injected animals not treated with ivermectin ( Fig. 5n ). Silencing of PKC-d 1 neurons with ivermectin/GluCl also increased CEm unit activity ( Fig. 5m , n, red symbols), which is consistent with our observation that PKC-d 1 CEl neurons inhibit CEm output neurons ( Fig. 3q-w) . The simplest interpretation of these data is that CEl off units are PKC-d 1 neurons, although this does not necessarily imply the converse.
Behavioural effect of silencing CE1 PKC-d 1 neurons
Finally, we tested the effect of suppressing PKC-d 1 neuronal activity on fear conditioning (see Methods). We initially investigated the effect of silencing during both training and testing, analogous to a pre-training lesion. Although ivermectin at the dose used (10 mg kg 21 ) did not significantly affect freezing in wild-type animals ( Supplementary Fig.  4a ), to avoid potential interactions between treatment with ivermectin and viral infection, in most experiments we also treated single subunitexpressing control animals (transgenic or wild-type animals injected 
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with GluCla or GluClb virus, respectively) with ivermectin. These control groups were not significantly different from each other (Supplementary Fig. 4b ) and were pooled for statistical analysis.
In some experiments (five to eight animals per group), when we used a high-titre (10 13 ml 21 ) preparation of AAV2:GluClb (ref. 14) , a significantly higher level of freezing was observed in experimental animals than in controls; however, in other experiments with different virus preparations, no difference between groups was detected (Supplementary Note 1). Quantitative histological analysis ( Supplementary Fig. 10 ) revealed considerable variation in the level and bilaterality of GluClb-YFP expression among individual animals ( Supplementary Fig. 5a -c). We therefore pooled data from multiple experiments (total n 5 54 animals/group) for statistical analysis. A randomized-block analysis of variance (ANOVA) 42 with six experimental and six control subjects assigned to each of nine blocks based on infection rate (total n 5 108; Supplementary Table 5 and Supplementary Fig. 5d -f) indicated a significant block 3 group interaction during both the CS presentation (F (8,90) 5 2.298, P , 0.05 by post-hoc Bonferroni t-test) and post-CS periods (F (8,90) 5 2.459, P , 0.05) but not during the baseline period (F (8,90) 5 1.41, P 5 0.205). Freezing was significantly higher in the experimental group only in the block with the highest infection rate ( Table 1 , Supplementary Table 5 and Supplementary Fig. 5e , f). Freezing in the experimental group was also significantly higher than in controls (including GluClab animals tested without ivermectin; n 5 6) among animals expressing GluClb bilaterally in the central nucleus at a level above the median infection rate ( Supplementary Fig. 7 ). There was no significant decrease in baseline locomotor activity or in the activity burst produced by the first presentation of the unconditioned stimulus during training ( Supplementary Fig. 8 ) in experimental animals, indicating that the increased freezing was not a consequence of either decreased locomotor activity or increased sensitivity to the unconditioned stimulus 13 . Freezing levels during the pre-training and pre-test baseline were unaffected by ivermectin in experimental animals (Supplementary Table 5 , Supplementary Figs 5 and 7, and data not shown).
Discussion
We have used genetically based methods to investigate the functional connectivity of a subpopulation of CEl GABAergic neurons identified by the expression of PKC-d. Our data suggest that these neurons participate in a recurrent inhibitory circuit within CEl that inhibits CEm output to brainstem centres that control freezing, consistent with earlier suggestions 9,12 . In the accompanying paper 16 two populations of CEl units are identified in vivo with opposite responses to the CS. The data presented here strongly suggest that CEl off units are PKC-d 1 neurons, linking molecular and physiological identity. Because PKC-d 1 neurons pre-exist in untrained animals, this linkage suggests that CEl off and CEl on units, which are robustly identifiable after conditioning ( Fig. 5k, l) , arise through plasticity-dependent changes in deterministic CEl subpopulations rather than by stochastic selection from a population of initially homogeneous cells.
The link between PKC-d 1 neurons and CEl off units is also consistent with complementary connectivity data in the two studies. For example, it has been shown that in vivo the activity of CEl off units is inversely correlated with the activity of CEl on units, suggesting reciprocal inhibition 16 . Our channelrhodopsin-assisted circuit mapping 38 and cell-specific The data are derived from the randomized-block ANOVA in Supplementary Table 5 (total n 5 108; six experimental and six control animals assigned to each of nine blocks), and illustrate the block with the highest level of viral infection in CEl (infection rate: the percentage of PKC-d 1 cells expressing GluClb-YFP; see Supplementary Fig. 10 ). The control group was pooled ( Supplementary Fig. 4b) Table 5 and Supplementary Fig. 5 . Control GluClab-expressing mice not treated with ivermectin were significantly different from the experimental group among animals showing bilateral AAV infection above the median rate (n 5 6-21; Supplementary Fig. 7 ).
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monosynaptic retrograde viral tracing 39 data directly demonstrate mutual inhibitory connections between PKC-d 1 and PKC-d 2 neurons in CEl. It has also been shown that exposure to CS both inhibits CEl off unit spiking and increases CEm unit activity 16 , with a short latency implying an inhibitory connection. Our data directly demonstrate inhibitory synapses from CEl PKC-d 1 neurons onto brainstem-projecting CEm output neurons, and indicate that silencing the former increases the tonic activity of the latter in vivo. Thus, our direct mapping of PKCd 1 synaptic connectivity in amygdala slices is consistent with inferences of CEl off unit connectivity based on correlative in vivo recordings (Fig. 5b) . Consistent with these electrophysiological and connectional data, genetic silencing of PKC-d 1 neurons yielded a statistically significant enhancement of conditional freezing (during both the CS-on and post-CS periods) among those animals with the highest level of AAV::GluClb infection in CEl. Nevertheless, these behavioural results should be interpreted with caution, given the variability in results between individual experiments (see Supplementary Note 1). Furthermore, although treatment with ivermectin caused a decrease in CEl off tonic spiking activity in GluClab-expressing animals, how this effect influences CS-evoked freezing, which is correlated with phasic CS response in CEl off unit activity 16 , is not yet clear.
Although the CEl circuitry defined here and in ref. 16 is remarkably consistent, the behavioural results in the two studies differ in some respects. For example, muscimol injection into CEl evoked freezing in unconditioned animals 16 , whereas selective silencing of PKC-d 1 neurons with ivermectin/GluCl did not. Furthermore, transient inhibition of CEl during training with muscimol attenuated fear conditioning 16 , whereas chronic silencing of PKC-d 1 neurons during both training and testing did not. We have not yet examined the behavioural effects of silencing PKC-d 1 neurons during training compared with testing, and this will be a significant question for future studies. Differences between the consequences of the inhibition of CEl by muscimol and those arising from the silencing of CEl PKC-d 1 neurons by ivermectin/ GluCl may reflect differences in the cellular specificity, efficiency or time course of the two types of manipulation (Supplementary Note 2).
The CEl/CEm microcircuit revealed by these companion studies has properties worthy of further investigation. For example, the mutual inhibitory connections between CEl off and CEl on units could provide a positive feedback loop to amplify CS-evoked activity in CEl on units (Fig. 5b) 43 . These antagonistic connections could also potentially encode different states, through stable imbalances in tonic activity 16 or different oscillatory regimes, that could influence the learning and/ or expression of conditioned fear. A currently unresolved paradox is 
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why, if CEl on units (like CEl off units) send inhibitory projections to CEm 16 , the activation of CEl on units by the CS results in increased rather than decreased activity of CEm output neurons (see Supplementary Note 3). Resolution of this paradox will require determining whether these two CEl populations target the same or different classes of CEm neuron 34 , and the relative strength of these connections. Genetically based synaptic tracing and functional manipulations of CEl on units should clarify this issue, and should also provide direct tests of their causal role in conditioned freezing and other emotional behaviours. The ability to identify and selectively manipulate PKC-d 1 and other molecularly defined CEl subpopulations prospectively 44, 45 should also open the way to investigating their roles in animal models of phobic or anxiety disorders, and in the mechanism of action of drugs used to treat such disorders 46 .
METHODS SUMMARY
Histochemical methods. Single-colour and double-label fluorescence in situ hybridizations were performed on fresh frozen sections, using RNA probes labelled with digoxigenin (Roche) and with 2,4-dinitrophenol (PerkinElmer). Immunofluorescence was performed on cryosections of tissue perfused with 4% paraformaldehyde, following standard protocols. Generation of PKC-d::GluCla-ires-Cre transgenic mice. A GluCla-ires-Cre cassette was inserted into PKC-d BAC clone RP23-283B12 (CHORI). The modified BAC was injected into FVB mouse embryos (GENSAT). Transgenic founders were backcrossed (n . 5) to C57Bl6/N. These mice are available through GENSAT 26 .
Pharmacogenetic silencing in vitro and in vivo. PKC-d::GluCla-ires-Cre transgenic or wild-type mice were injected with about 10 9 particles of AAV::GluClb (or, in control experiments, AAV::GluCla) into the central amygdala and allowed to recover for 4 weeks. For fear conditioning experiments, mice were habituated and then injected with ivermectin (10 mg kg 21 ; Phoenix) on day 1. On day 2, animals received tone/foot-shock pairings in context A (Coulbourn, Med Associates). On day 3, (and for in vivo recordings also on days 6 and 8), animals were placed in context B and freezing was scored before (baseline), during and after CS presentations. For in vitro recordings, acute brain slices were prepared and superfused with 20 nM ivermectin in artificial cerebrospinal fluid to induce pharmacogenetic silencing. Single-unit recordings were performed in freely behaving animals as described 16 .
Optogenetic circuit dissection. PKC-d::GluCla-ires-Cre transgenic mice were injected with 10 9 particles of Cre-dependent ChR2 AAV into the central amygdala, and (in some animals) CTB into the PAG for retrograde labelling. Four weeks later, neurons were stimulated with light, in acute brain slices, through a 200-mm optical fibre (Thorlabs) emitting 5-10 mW of 473-nm laser light (Crystalaser). Virus based trans-synaptic tracing. PKC-d::GluCla-ires-Cre transgenic mice were injected sequentially into the central amygdala with 10 4 particles of AAV encoding Cre-dependent TVA and rabies B19 glycoprotein. Three weeks later, animals were injected in the same site with 10 5 particles of RV DG rabies virus pseudotyped with EnvA, and analysed one week later. All animal experiments were conducted under protocols approved by the Caltech Institutional Animal Care and Use Committee (IACUC) and the Salk Institute Biosafety Committee. . Transgenic mice were generated by pronuclear injection of CsCl-prepared BAC DNA linearized with P-SceI in FVB embryos 26 , which yielded two independent transgenic lines with indistinguishable expression patterns. One of them was backcrossed for more than five generations to C57Bl6/N. Germline transmission and genotyping of transgenic offspring were traced by PCR on genomic tail DNA (primer set 59-GCTACA TCAAGGCCATCGAC-39 and 59-AACTCCAGCAGGACCATGTGATCG-39). The line is available through GENSAT. In situ hybridizations. In situ hybridization was performed on fresh frozen brain sections 20 mm thick. Processing of sections, hybridization and probe detection for single colour in situ hybridizations were performed with standard protocols 19 , with the following specifications: probes were cloned from whole mouse brain cDNA library (Invitrogen; GAD65 primer set 59-ATCTCCAACATGTATGCCATGCTCATT GCC-39 and 59-TTACAAATCTTGTCCGAGGCGTTCGA-39; corticotropinreleasing hormone primer set 59-AACGGAGTAAGGGCAGGAATGGAGACA GAG-39 and 59-GTTGCTGTGAGCTTGCTGAGCTAACTGCTCTGC-39; enkephalin primer set 59-TAGGGTCCAAGCTCTCATTGAGGCACCCGG-39 and 59-GCTTCAGAACCGCATAAAGCCCCCGTAT-39; oxytocin receptor 59-CTG GCCCACCAGGCCAGCCGCTGGGTGGTG-39 and 59-AATCCCCATCTCCT TGGGAATTTTAGGAT-39) transcribed from linearized templates in pTeasy (Promega) or pCR2.1 (Invitrogen) using Sp6 polymerase (9PIP108; Promega) or T7 polymerase (9PIP207; Promega) and digoxigenin-labelled nucleotide mix (11277073910; Roche), used at a final concentration of 1 mg ml 21 , and detected with anti-digoxigenin-horseradish peroxidase, Fab fragments (1-207-733; Roche).
METHODS
Processing of sections and hybridization for double-label fluorescence in situ hybridization were performed as above, with the following specifications: digoxigenin and 2,4-dinitrophenol-UTP (NEL555001; PerkinElmer) probe pairs were used at a final concentration of 1 mg ml 21 each. For detection, sections were each blocked first in 20% sheep serum in 0.1 M Tris-HCl pH 7.5, 0.15 M NaCl, 0.05% Tween 20 and NEN-blocking solution (PerkinElmer) for 30 min. Digoxigeninlabelled probe was detected with anti-digoxigenin horseradish peroxidase (Roche) (1:500 dilution, 2 h), biotin-tyramide (1:100 dilution, 8 min, room temperature (20-25 uC); PerkinElmer), Vecta Stain Elite ABC Kit (PK-6100; Vector) and Cy3-Tyramide (Cy3 tyramide NEL704A, 1:50 dilution, 1 h; PerkinElmer). Horseradish peroxidase was inactivated by incubation for 1 h in 3% H 2 O 2 in PBS, followed by heat denaturation at 85 uC for 5 min in 10 mM tris(hydroxymethyl) aminomethane, 1 mM EDTA pH 7.5. Sections were blocked again as above and 2,4-dinitrophenol (DNP)-labelled nucleotides were detected with anti-DNP horseradish peroxidase (1:500, 2h), DNP-tyramide, anti-DNP horseradish peroxidase (1:500 dilution, 2 h, all TSA DNP Kit, NEL747A; PerkinElmer) and fluorescein-tyramide (1:100 dilution, NEL701; PerkinElmer). Sections were mounted in Fluoro Gel (17985-10; Electron Microscopy Sciences). All washing steps and incubations were performed in accordance with the respective manufacturers' recommendations. Sections were viewed under a Zeiss Axioscope microscope and a Leica TCS SP confocal microscope. Immunofluorescent labelling. For immunofluorescent labelling, mice were transcardially perfused with 4% paraformaldehyde in PBS. Brains were removed and cryoprotected for 16 h at 4 uC in 15% sucrose. Cryo-sections 20-30 mm thick were dried in air for 30 min and then rehydrated in PBST (PBS plus 0.1% Triton X-100). In some instances, immunoreactivity was increased by incubating the slides in 10 mM sodium citrate, 0.05% Tween 20 pH 6 for 10 min at 95 uC. Nonspecific binding was blocked with 1% BSA in PBST for 30 min. Primary antibodies (mouse anti-PKC-d (610398; BD Biosciences), guinea-pig anti-dynorphin (GP10110; Neuromics), rabbit anti-GFP (A11122; Invitrogen), rabbit anti-hrGFP (240142; Stratagene), mouse anti-NeuN (MAB377; Chemicon), goat anti-CTB (703; List) diluted 1:300-1:1,000 in blocking solution, were incubated for 16 h at 4 uC. Standard secondary antibodies (Invitrogen) in blocking solution were incubated for 3 h at room temperature. Unbound primary and secondary antibodies were each washed by incubation three times in PBST for 10 min. Sections were mounted in Fluoro Gel (17985-10; Electron Microscopy Sciences) and viewed under a Zeiss Axioscope microscope and a Leica TCS SP confocal microscope. Animal maintenance. Animals were group housed at 23 uC with ad libitum access to food and water in a 13-h day/11-h night cycle, with the day starting at 07:00. Histological analysis. All histological quantifications (Fig. 2i, m , Supplementary  Figs 2e , j, 5, 7 and 10, and Supplementary Tables 1 and 5) are based on at least three coronal sections spaced equidistantly along the rostro-caudal axis of the central amygdala.
The intrinsic fluorescence of GluCla2CFP or GluClb-YFP can be readily detected in live brain slices ( Fig. 4a and 5c-e and Supplementary Fig. 9a, b ). In the perfusion-fixed tissue used for all histological analysis, however, the fluorescent signal is substantially weaker. GFP immunofluorescent labelling directed against its CFP or YFP tag was therefore used wherever possible for more accurate results ( Fig. 1b-h , j-l and Supplementary Figs 2b-d and 5 ). However, this immunohistochemical method could not be used to quantify the extent of infection by AAV::GluClb-YFP in PKC-d::GluClaCFP-iCre transgenic mice, because of cross-reactivity of the anti-GFP antibody with the transgene-encoded CFP. The fraction of virally infected PKC-d 1 neurons in PKC-d::GluClaCFP-iCre transgenic brains was therefore estimated by quantifying the number of cells expressing intrinsic YFP fluorescence (which could be spectrally distinguished from the endogenous CFP fluorescence of the GluCla transgene). However, because this intrinsic fluorescence signal underestimates the extent of viral infection in perfusion-fixed tissue (see above), we constructed a standard curve by using wild-type mice infected with AAV:GluClb-YFP virus, in which the number of infected cells measured by using native YFP fluorescence was plotted against the number of infected PKC-d 1 cells measured by using double-immunofluorescence staining with anti-GFP and anti-PKC-d antibodies ( Supplementary Fig.  10 ). This standard curve was then used to estimate the fraction of PKC-d 1 cells that would have been detectable by direct immunofluorescence labelling for GFP, on the basis of the quantification of native YFP fluorescence. In the behavioural experiments in which wild-type and PKC-d::GluCla-CFP-iCre transgenic animals were classified on the basis of their infection rates (Table 1 , Supplementary Table 5 and Supplementary Figs 5 and 7) , this estimation method was applied to all experimental groups, including wild-type animals. Electrophysiological slice recordings. Standard mouse brain slice preparation and whole-cell recording were performed as described 14 . In brief, coronal sections 250 mm thick were prepared with a Vibratome (VT1000S; Leica), using ice-cold glycerol-based artificial cerebrospinal fluid (composition in mM: 252 glycerol, 1.6 KCl, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 2.4 CaCl 2 , 18 NaHCO 3 , 11 glucose, oxygenated with 95% O 2 /5% CO 2 ). Slices were allowed to recover for at least 1 h at 32 uC and kept at room temperature in standard artificial cerebrospinal fluid (ACSF; composition in mM: 126 NaCl, 1.6 KCl, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 2.4 CaCl 2 , 18 NaHCO 3 , 11 glucose, oxygenated with 95% O 2 /5% CO 2 ). Cells expressing CFP or YFP were detected by infrared differential interference contrast and fluorescence video microscopy (Olympus BX51). Whole-cell voltage and current recordings were performed at 30 uC with a MultiClamp 700B amplifier and Digidata 1440A (Molecular Devices). The patch pipette, with a resistance of 5-8 MV, was filled with an intracellular solution containing (in mM) 135 potassium gluconate, 5 EGTA, 0.5 CaCl 2 , 2 MgCl 2 , 10 HEPES, 2 MgATP and 0.1 GTP, pH 7.2, 280-300 mosM. Data were sampled at 10 kHz, filtered at 3 kHz and analysed with pCLAMP 10 software. Electrophysiological characterization of PKC-d 1 cells. The relation of genetic marker and electrophysiological type was analysed with Fisher's exact test with the null hypothesis that PKC-d 1 cells have the same proportion of late-firing neurons as do CEl neurons as a whole. We recorded 38 CEl neurons without knowing their genetic subtypes, 21 of which were late-firing neurons; 14 of the 17 non-late-firing neurons were regular spiking cells, and 3 were low-threshold bursting cells (Supplementary Tables 2 and 3 ). We also recorded 57 PKC-d 1 neurons on the basis of their CFP expression, and found 49 of them to be latefiring neurons and 8 of them to be non-late-firing neurons (all eight of these cells were regular spiking cells; Supplementary Table 4 ). Fisher's exact test revealed ARTICLE RESEARCH that PKC-d 1 neurons have a relatively homogeneous electrophysiological property of late-firing neurons in comparison with CEl neurons as a whole. Stereotaxic surgery. Male mice 2-4 months old were deeply anaesthetized with either ketamine/xylazine or isoflurane, injected intraperitoneally with 500 ml of 20% mannitol (Phoenix Pharmaceuticals) and placed in a stereotaxic frame (Kopf). The skull was exposed and perforated with a stereotaxic mounted drill at the desired coordinates (Supplementary Table 6 ). For postoperative care, mice were injected intraperitoneally with ketoprofen (2 mg per kg body weight) and supplied for 10 days with drinking water containing 80 mg l 21 trimethoprim, 400 mg l 21 sulphamethoxazole and 200 mg l 21 ibuprofen. Viral injections. Viral particles were delivered unilaterally by stereotaxic (see above) injection with through stereotaxic mounted motor-driven 32-gauge 45u bevelled steel cannulas (Micro 4 controller equipped with Hamilton system; World Precision Instruments) or glass capillaries (Micro4 controller equipped with Microject system; World Precision Instruments) to one to four injection sites per hemisphere at flow rates of 50-100 nl min 21 . Pharmacogenetic silencing in vitro. Mice were unilaterally injected with a total of 2 ml of AAV GluCla or GluClb virus (serotype 2; (1-10) 3 10 12 particles ml 21 in PBS) into the central amygdala (see above). Four weeks after surgery, slices (see above) were perfused for 20 min with 20 nM ivermectin in ACSF to induce pharmacogenetic silencing. Pharmacogenetic silencing in vivo. Mice were injected bilaterally with a total of 2 ml of AAV GluCla or GluClb virus (serotypes 2, 5 and 8; (1-10) 3 10 12 particles ml 21 in PBS) into the central amygdala (see above). Four weeks after surgery, on day 1, animals were habituated for 20 min to context A and given a single intraperitoneal dose of 1% ivermectin injectable solution (Phoenix) at 10 mg per kg 21 body weight, or vehicle. On day 2, animals were fear-conditioned in context A connected to a shock scrambler (Coulbourn Scientific or Med Associates fear conditioning systems were used). After 20 min, mice were exposed to training trials of tone (85 dBA, 2 kHz) for 20 s, immediately followed by a foot shock (0.5 mA) for 2 s, with an inter-trial interval of 198 s. To avoid masking of the consequences of the experimental manipulation by ceiling and floor effects, the number of training trials (three to six) was adjusted such that freezing levels averaged about 50% in the genetic/viral control. During the training session, behaviour was recorded with infrared sensors (Coulbourn fear conditioning system) or video cameras (Med Associates fear conditioning system). On day 3, mice were placed in context B, differentiated from context A by a modified wall, floor and ceiling. Before each trial, all surfaces were cleaned with water and disinfectant. After a 5-min baseline period, two test trials of a 30-s CS followed by a 1-min post-CS period were presented. Freezing was recorded with video cameras and scored either manually by an observer blind to the experimental group of the animal (Coulbourn fear conditioning system) or electronically (Med Associates fear conditioning system). Freezing during the CS and post-CS periods are represented as bins of these two test trials. Baseline freezing was averaged over 3 min before the first CS presentation.
To investigate the relationship between freezing and the extent of viral infection ( Supplementary Fig. 5a-c) , freezing data were correlated with the fraction of PKC-d 1 expressing GluClb, estimated as described above with native fluorescence for YFP and the standard curve in Supplementary Fig. 10 .
To investigate differences in freezing between experimental and control groups, freezing in the experimental group was compared with genetic/viral control groups by a two-way ANOVA with infection rate as the blocking variable (Supplementary Table 5 and Supplementary Fig. 5d-f ). Retrograde tracing with CTB. CTB (0.5% in PBS; List) was delivered by stereotaxic (see above) iontophoresis with a positive-pulsed current of 5 mA for 2 min. The animals were killed 1 week after injection, and the brains were processed for IHC. Optogenetic circuit dissection. Mice were unilaterally injected with a total of 2 ml of Cre-dependent AAV ChR2 virus (serotypes 2 and 5; (1-10) 3 10 12 particles ml 21 in PBS) into the central amygdala (see above). Slices (see above) were stimulated with an optic fibre (200 mm core diameter; ThorLabs) coupled to a 473-nm laser (CrystaLaser) and mounted on a three-dimensional micromanipulator (MPC365; Sutter) with the fibre end positioned on the edge of CEl. Cre-dependent monosynaptic tracing with rabies virus. Cre-expressing cells were primed for subsequent infection and monosynaptic retrograde spread of EnvA-pseudotyped, glycoprotein gene-deleted rabies virus, by stereotaxic injection (see above) of 180 nl of Cre-dependent AAV expressing the avian receptor protein TVA and rabies B19 glycoprotein (AAV9-pEF1a-FLEX-GTB) into the central amygdala. The genomic structure of AAV9-pEF1a-FLEX-GTB is L_ITR-EF1a Pro-Kozak-(FLEX cassette 48 containing GFP-T2A-hTVA-E2A-hB19G)-STOP-WPRE-polyA-R_ITR. The start ATG has been deleted from all three genes, and transcription start is mediated by a Kozak sequence that precedes the FLEX cassette 49 . Genes were linked together through the use of 2A elements, which permit the expression of multiple genes under the control of a single promoter 50, 51 . Both the TVA and B19G genes were codon-optimized for expression in mammalian cells. The virus was prepared through a crude lysate extraction of transfected 293T cells, and had a genomic titre of 10 8 particles ml 21 . Although reverse-complemented GFP is detectable in the AAV genome, Cre-expressing cells expressed undetectable levels of GFP, either through native fluorescence or antibody-amplified imaging, whereas TVA and B19G appeared to express normally.
Three weeks later, mice were injected at the same site with 180 nl of glycoprotein gene-deleted rabies virus 52 that had been pseudotyped with the avian sarcoma leucosis virus glycoprotein EnvA 40 . The glycoprotein gene had been replaced with mCherry. The resulting virus, (EnvA)SAD-dG-mCherry, was incapable of infecting mammalian neurons in the absence of its binding partner, TVA, and could not spread retrogradely in the absence of the rabies B19 glycoprotein 39 . The biological titre of 10 9 particles ml 21 was determined through infection of TVA-expressing 293T cells. One week after the second injection, the animals were killed and the brains were processed for IHC. Pharmacogenetic silencing with in vivo electrophysiological recordings. Mice were injected bilaterally with a total of 2 ml of AAV GluCla virus (serotype 2;
(1-10) 3 10 12 particles ml 21 in PBS) into the central amygdala (see above). Four weeks later, on day 1, mice were habituated to four CS presentations (total CS duration 30 s, consisting of 50-ms pips repeated at 0.9 Hz, 2-ms rise and fall; pip frequency 7.5 kHz, 80 dB sound pressure level) in context B. On day 2, mice were conditioned with five CS/unconditioned stimulus (0.6 mA, 1 s) pairings with intertrial intervals of 20-180 s in context A (Coulbourn fear conditioning system). On days 3, 6 and 8, mice were exposed to four CS presentations in context B. During these periods, individual neurons were recorded extracellularly in freely behaving mice. Spikes of individual neurons were sorted by time-amplitude window discrimination and template matching as described previously 53, 54 . Cluster quality was verified by quantifying the cluster separation 54 (Supplementary Fig. 8 ). Unit isolation was verified by using autocorrelation and cross-correlation histograms. Spike rasters and histograms were constructed by aligning sweeps relative to the CS onset, and CS-evoked responses were normalized to baseline activity using a Z-score transformation. Detailed methodological information about in vivo single-unit recordings of central amygdala neurons is presented in ref. 16 .
